Virology News
207.7K views | +1 today
Virology News
Topical news snippets about viruses that affect people.  And other things. Like Led Zeppelin. And zombies B-)
Curated by Ed Rybicki
Your new post is loading...
Your new post is loading...
Scooped by Ed Rybicki
January 27, 2016 7:05 AM
Scoop.it!

As Zika Virus Rises, Vaccine Development Gets Attention

As Zika Virus Rises, Vaccine Development Gets Attention | Virology News | Scoop.it
With fears about the Zika virus outbreak in South America spreading, experts are turning toward developing a vaccine that could prevent the spread of the virus.
Ed Rybicki's insight:

One would hope so...of course, the time to act would have been before it got to S America, let alone N America!

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 10:18 AM
Scoop.it!

New Tests for Zika in the Works | The Scientist Magazine®

New Tests for Zika in the Works | The Scientist Magazine® | Virology News | Scoop.it
To answer questions about the risks of Zika virus infection, researchers need better diagnostics.
Ed Rybicki's insight:

OK, I'll make some proteins then B-)

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 4:08 AM
Scoop.it!

Dog Flu Spreading Fast Across U.S., Vets Issue Guidelines

Dog Flu Spreading Fast Across U.S., Vets Issue Guidelines | Virology News | Scoop.it

Animal health officials share what dog owners should know about the virus and what to do if their pets come down with it.

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 3:10 AM
Scoop.it!

Flu virus hijacking tactics pave way for new treatment

Flu virus hijacking tactics pave way for new treatment | Virology News | Scoop.it

Flu virus hijacking tactics revealed by scientists
by Kate Wighton
06 January 2016


Scientists at Imperial College London have discovered how flu viruses 'hijack' cell machinery when they infect the body.

The findings, published in the journal Nature, may pave the way for more effective antiviral treatments for pandemics and for seasonal flu, which infects over 800 million people worldwide every year.

In the research, the team used hamster-chicken hybrid cells to discover why avian influenza virus (bird flu) cannot usually infect mammal cells.

Up until now we haven’t understood why the flu virus has to change in order to hijack the human cell machinery
– Professor Wendy Barclay
Study Author
They found that a particular host protein – called ANP32A – which is also found in human cells, acts as an ‘insider’ and helps the virus replicate once the virus has gained entry into the cell.  Bird flu viruses can’t use the mammalian ANP32A unless they carry a particular mutation.

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 3:01 AM
Scoop.it!

Inovio Pharma, GeneOne Life Science Enter Collaboration for Zika Virus DNA Vaccine

Inovio Pharma, GeneOne Life Science Enter Collaboration for Zika Virus DNA Vaccine | Virology News | Scoop.it
Inovio Pharma (INO), GeneOne Life Science Enter Collaboration for Zika Virus Vaccine

GeneOne Life Science announced the initiation of a collaborative research program with Inovio Pharmaceuticals (Nasdaq: INO) to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection.

Inovio and its collaborators are leveraging their past experience in designing and testing novel DNA-based vaccines for related viruses including the West Nile, dengue, and chikungunya viruses. Moreover, Inovio and GeneOne are currently collaborating on two phase I stage vaccine candidates for severe infectious diseases: INO-4212, a vaccine for Ebola infection and GLS-5300, a vaccine for MERS infection. The Zika virus vaccine candidate is currently undergoing preclinical animal studies to evaluate its immunogenicity.

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 2:56 AM
Scoop.it!

Antibodies may provide 'silver bullet' for Ebola viruses

Antibodies may provide 'silver bullet' for Ebola viruses | Virology News | Scoop.it
Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported today in the journal Cell that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
No comment yet.
Scooped by Ed Rybicki
January 26, 2016 2:53 AM
Scoop.it!

WHO issues Ebola survivor guidance as cases show virus persistence

WHO issues Ebola survivor guidance as cases show virus persistence | Virology News | Scoop.it
The guidance emphasizes integrated care for diverse needs of survivors.
Ed Rybicki's insight:

There is really no end in sight....

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 2:32 AM
Scoop.it!

CDC expands Zika virus alert to 22 locations

CDC expands Zika virus alert to 22 locations | Virology News | Scoop.it
The CDC added eight tropical destinations to a travel alert about an mosquito-borne illness linked with a severe birth defect.
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 11:01 AM
Scoop.it!

Zika: Olympics plans announced by Rio authorities

Zika: Olympics plans announced by Rio authorities | Virology News | Scoop.it
Brazil's authorities announce plans to prevent the spread of the mosquito-borne Zika virus in Rio de Janeiro during the Olympic Games later this year.
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:43 AM
Scoop.it!

Man flu is real because oestrogen protects women from influenza

Man flu is real because oestrogen protects women from influenza | Virology News | Scoop.it

New research has - once again - appeared to prove the existence of the much-contested 'man flu'.

The study, published by researchers at Johns Hopkins University, suggests that the female sex hormone oestrogen could help women combat the virus, leaving lesser-protected men out in the cold.

Oestrogen, which is found at considerably higher levels in women than in men, was found to reduce the replication of the 'influenza A' virus in nasal cells, thereby initiating antiviral effects against the disease.

Ed Rybicki's insight:

Well, of course?!

No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:40 AM
Scoop.it!

Researchers Use Modified Rabies Viruses To Map The Brain

Researchers Use Modified Rabies Viruses To Map The Brain | Virology News | Scoop.it
Researchers have figured out a way to leverage rabies to not kill the brain, but instead map it.
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:35 AM
Scoop.it!

Zika: a rare benign virus suddenly turns nasty, and heads for the US

Zika: a rare benign virus suddenly turns nasty, and heads for the US | Virology News | Scoop.it
Focus on the apparent association between Zika infection in pregnant women and the birth of babies with small brains is still largely circumstantial, but if true, is alarming.
No comment yet.
Scooped by Ed Rybicki
January 22, 2016 6:24 AM
Scoop.it!

Implementation of the malaria candidate vaccine RTS,S/AS01 - The Lancet

Implementation of the malaria candidate vaccine RTS,S/AS01 - The Lancet | Virology News | Scoop.it
As vaccine manufacturers tackle increasingly intractable pathogens, vaccines will be developed that show efficacy, but that are less efficacious than established vaccines. Consequently, regulatory and public health authorities will be faced with difficult decisions about whether such vaccines should be recommended for implementation and, if so, under what circumstances. The RTS,S/AS01 malaria candidate vaccine provides an important example of such a challenge.

After a long period of development,1, 2 a large phase 3 trial3 of RTS,S/AS01 in children aged 5–17 months at first vaccination showed a vaccine efficacy of 28·3% (95% CI 23·3–32·9%) against clinical malaria in children who received three doses, and of 36·3% (31·8–40·5%) in those given a fourth dose, during 48 months of follow-up. The vaccine also provided significant protection against severe malaria and hospital admissions in the group of children who received a fourth dose.3 An average of 1774 cases (95% CI 1387–2186) of clinical malaria were averted per 1000 children vaccinated in the four-dose group. An unexplained increase in incidence of meningitis was identified as a safety signal. Efficacy was lower in infants who received their first dose of vaccine aged 6–12 weeks than in children aged 5–17 months. Could this vaccine with restricted efficacy still have a useful role in malaria control? In The Lancet, Melissa Penny and colleagues4 provide some important new information that suggests that it could.
No comment yet.
Scooped by Ed Rybicki
January 27, 2016 7:03 AM
Scoop.it!

Obama calls for rapid Zika research as virus seen spreading

Obama calls for rapid Zika research as virus seen spreading | Virology News | Scoop.it
President Barack Obama on Tuesday called for the rapid development of tests, vaccines and treatments to fight the mosquito-transmitted Zika virus, which has been linked to birth defects and could spread to the United States in warmer months.
Ed Rybicki's insight:

Hee-eee-ey: over here!!!  I'd love some money to work on making Zika antigens!?

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 4:22 AM
Scoop.it!

Putin Says Russia Has Made “Highly Effective” Ebola Vaccine

Putin Says Russia Has Made “Highly Effective” Ebola Vaccine | Virology News | Scoop.it
One Russian politician says he expects the vaccine to earn Moscow "billions of dollars."
Ed Rybicki's insight:

Sounds like it's antibodies, but they don't say!  And yet again - a country that researched Ebola in the Cold War years now has a therapy.  Interesting, that...

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 3:12 AM
Scoop.it!

How A Hepatitis C Virus Peptide Destroys Other Viruses

How A Hepatitis C Virus Peptide Destroys Other Viruses | Virology News | Scoop.it
It's been known that the HCV α-helical (AH) peptide has broad antiviral properties—the same property that allows the peptide to hijack host cell structures for HCV replication also produces ruptures in viral membranes, exposing the viral genome to host enzymes that destroy the pathogens. However, the development of therapies inspired by the actions of the AH peptide has been limited by the lack of knowledge about why it selectively attacks the viral envelope but not host cell membranes.
No comment yet.
Scooped by Ed Rybicki
January 26, 2016 3:04 AM
Scoop.it!

Scientists develop hydrogen 'nano reactor' by hiding bacteria genes inside a virus shell

Scientists develop hydrogen 'nano reactor' by hiding bacteria genes inside a virus shell | Virology News | Scoop.it
Researchers in the US have developed a virus-like biomaterial that catalyses the formation of hydrogen inexpensively and cleanly, which could lead to new environmentally friendly ways of producing biofuel.

The biomaterial is produced by placing a modified enzyme inside the protective protein shell of a virus, called a capsid. The resulting 'nano reactor' catalyst is 150 times more efficient than the unaltered form of the enzyme.
Ed Rybicki's insight:

Phages: what can I say.  Nature's nanotech enablers B-)

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 3:00 AM
Scoop.it!

EPO Revokes Monsanto Patent On Virus-Resistant Melon

EPO Revokes Monsanto Patent On Virus-Resistant Melon | Virology News | Scoop.it
The European Patent Office on 20 January revoked a patent held by Monsanto on virus-resistant melons for technical reasons, much to the glee of opponents of patents on conventional plants. [updated…
Ed Rybicki's insight:

Now this is NOT a victory for anti-GMO activists, but more for folk who are against the patenting of natural genomes - which this is, in fact, as "Monsanto was claiming melons with a natural resistance to plant viruses."  Which is not a good thing, in my mind, because it would mean companies could mine germ plasm collections for useful traits and then patent them.

No comment yet.
Scooped by Ed Rybicki
January 26, 2016 2:55 AM
Scoop.it!

Flawed U.S. response to pig virus outbreaks highlights vulnerabilities

Flawed U.S. response to pig virus outbreaks highlights vulnerabilities | Virology News | Scoop.it
The U.S. Department of Agriculture (USDA) is taking heat from Congress’s nonpartisan watchdog agency over the way it has responded to outbreaks of so-called emerging diseases in livestock. A U.S. Government Accountability Office (GAO) report faults USDA for not doing enough to respond to and investigate viral outbreaks in pigs in 2013 and 2014, as well as not doing nearly enough afterward to prevent and reduce the impact of future outbreaks.

In particular, GAO concluded that USDA erred by not requiring veterinarians and producers to report diseased animals, and by relying on voluntary reports instead. And it warns that new USDA policies aimed at avoiding similar problems in the future may prove difficult to implement. The report specifically refers to what USDA calls emerging diseases—economically damaging diseases that are either new to the United States or appear to be becoming more deadly or dangerous.

The findings are important, lawmakers and outside observers say, because they suggest the government is not fully prepared to track and respond to emerging diseases that could harm animal health, push up food prices, and, for some viruses, potentially spread to humans.
Ed Rybicki's insight:

Good incubators for flu viruses, pigs - and who knows what is mixing in them??

Scooped by Ed Rybicki
January 26, 2016 2:37 AM
Scoop.it!

Dozens of people are quarantined in Bangkok to prevent the spread of MERS virus

Dozens of people are quarantined in Bangkok to prevent the spread of MERS virus | Virology News | Scoop.it
In South Korea last year, a single person spread the virus causing Middle East Respiratory Syndrome (MERS) to 186 others, 36 of whom died as a result. Now Thailand, having identified the virus in a visitor from Oman on Friday (Jan. 22), has since placed dozens of people in quarantine. It's the second MERS case that Thailand...
No comment yet.
Scooped by Ed Rybicki
January 26, 2016 2:31 AM
Scoop.it!

Army roped in to help contain Ebola virus in Sierra Leone

Army roped in to help contain Ebola virus in Sierra Leone | Virology News | Scoop.it
Sierra Leone’s army has been requested to assist to better protect the country against the ebola epidemic, following the World Health
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:45 AM
Scoop.it!

One medicine shows multi-viral success

One medicine shows multi-viral success | Virology News | Scoop.it
A new drug has shown promise against both Marburg virus and Ebola. This may not be as surprising as it first seems, given the genetic similarities between the two viruses.
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:42 AM
Scoop.it!

Drug shows promise for halting Epstein-Barr virus

Drug shows promise for halting Epstein-Barr virus | Virology News | Scoop.it
Scientists have discovered they can use the drug rapamycin to freeze the advance of cancer-causing Epstein-Barr virus in cells by putting the cells into a dormant state.
No comment yet.
Scooped by Ed Rybicki
January 25, 2016 7:38 AM
Scoop.it!

This Is What Could Happen If Zika Virus Spreads In The US

This Is What Could Happen If Zika Virus Spreads In The US | Virology News | Scoop.it
Experts said that it is just a matter of time before the mosquito-borne Zika virus arrives in the U.S. Here's what could happen once an outbreak occurs.
No comment yet.
Scooped by Ed Rybicki
January 22, 2016 7:36 AM
Scoop.it!

Virus chequers: A newly emerging disease is threatening the Americas

Virus chequers: A newly emerging disease is threatening the Americas | Virology News | Scoop.it
A newly emerging disease is threatening the Americas
No comment yet.